EMA Says Pregnant Women May Safely Get mRNA COVID-19 Vaccines

A European Medicines Agency (EMA) panel said that current real-world evidence shows that messenger RNA (mRNA)-based COVID-19 vaccines don’t present added safety risks for pregnant women.

An EMA task force reviewed several studies involving an estimated 65,000 pregnancies at different trimesters and found no sign of an increased risk of pregnancy complications, miscarriages, preterm births or adverse effects in the unborn babies following mRNA COVID-19 vaccination.

The task force said that the benefits of receiving an mRNA COVID-19 vaccine from Pfizer/BioNTech or Moderna outweighed any potential risks for expectant mothers and their unborn babies.